Zhou, L., Qi, L., Jiang, L., Zhou, P., Ma, J., Xu, X., & Li, P. (2014). Antitumor Activity of Gemcitabine Can Be Potentiated in Pancreatic Cancer through Modulation of TLR4/NF-κB signaling by 6-Shogaol. Springer US.
استشهاد بنمط شيكاغوZhou, Ling, Lianwen Qi, Lifeng Jiang, Ping Zhou, Jiang Ma, Xiaojun Xu, و Ping Li. Antitumor Activity of Gemcitabine Can Be Potentiated in Pancreatic Cancer Through Modulation of TLR4/NF-κB Signaling By 6-Shogaol. Springer US, 2014.
MLA استشهادZhou, Ling, et al. Antitumor Activity of Gemcitabine Can Be Potentiated in Pancreatic Cancer Through Modulation of TLR4/NF-κB Signaling By 6-Shogaol. Springer US, 2014.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.